By 1998, the drug, then known as PS-341, had advanced into early-stage human testing.

FORBES: Magazine Article

There were still reasons to doubt the new drug, then called PS-341.

FORBES: Magazine Article

The new drug, known as MLN341 or PS-341, reduced levels of proteins used to monitor the disease in 77% of 78 patients.

FORBES: Where Are Cancer's Miracle Drugs?

Through 1997, Adams and his team amassed animal data on PS-341, in the process cementing relationships with more than a dozen academic researchers.

FORBES: Magazine Article

Julian Adams , who is now Millennium's vice president of target discovery, discovered PS-341 at a company that was eventually bought by Millennium.

FORBES: Where Are Cancer's Miracle Drugs?